0000000000278053

AUTHOR

Wolfgang Opferkuch

showing 2 related works from this author

Treatment with essential amino acids in patients on chronic hemodialysis: a double blind cross-over study.

1978

Patients on chronic hemodialysis may suffer from a latent protein deficiency, and therapy with essential amino acids has been recommended. In a double blind cross-over study, 13 hemodialysis patients received orally 15.7 g of essential amino acids daily over a 3-month period. Patients were on a liberal diet, containing 1 g of protein per kilogram of body weight per day. Hemodialysis was adequate. Therapy resulted in an increase in urea, uric acid, C3 c complement factor and a fall in C4. Lysine levels increased and phenylalanine fell. Malnutrition could not account for the observed metabolic changes, which are more likely due to uremic metabolic disturbances. A liberal diet of 1 g of protei…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentMedicine (miscellaneous)PhenylalanineComplement factor Ichemistry.chemical_compoundGlomerulonephritisRenal DialysisInternal medicineProtein DeficiencyMedicineHumansPrealbuminchemistry.chemical_classificationClinical Trials as TopicNutrition and DieteticsPyelonephritisbusiness.industryTransferrinComplement C3Middle Agedmedicine.diseaseCrossover studyAmino acidRetinol-Binding ProteinsMalnutritionEndocrinologychemistryBiochemistryUreaUric acidFemaleHemodialysisAmino Acids EssentialbusinessThe American journal of clinical nutrition
researchProduct

Double-blind cross-over study with oral alpha-ketoacids in patients with chronic renal failure.

1980

In 15 ambulatory patients with renal insufficiency (creatinine clearance, 9.9 +/- 3.0 ml/min) the effect of oral supplementation with alpha-ketoacids has been compared with that of placebo. The protein intake amounted to 0.55 g protein per kilogram body weight of high biological value, as estimated by dietary recordings. After a control period of 3 months the patients received, in a double-blind study, 1.05 g alpha-ketoacids/10 kg body weight per day or a placebo for 6 weeks with a subsequent cross-over. Fasting blood samples were analyzed at 3-week intervals for routine laboratory parameters and 17 proteins. Anthropometric and clinical data have been recorded every 3 weeks. While therapy w…

AdultMalemedicine.medical_specialtyMedicine (miscellaneous)Renal functionAlpha (ethology)PlaceboGastroenterologyPhosphatesPlacebosElectrolytesDouble-Blind MethodInternal medicinemedicineHumansClinical Trials as TopicNutrition and Dieteticsbusiness.industrynutritional and metabolic diseasesBiological valueBlood ProteinsAnthropometryMiddle AgedCrossover studyKeto AcidsDietClinical trialEndocrinologyCreatinineAmbulatoryKidney Failure ChronicFemalebusinessThe American journal of clinical nutrition
researchProduct